Key facts
- It has raised $7.0M; the latest was Early Stage VC ($7.0M) in Feb 2026.
- Notable investors include European Innovation Council, Almi Invest, Illumina Ventures, Life Science Invest, Nordic Science Investments — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for CubaseBio
- ·The full record, as it builds
Funding rounds
No funding rounds for CubaseBio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CubaseBio
Operator of a spatial biology company intended to build tools that reveal biology in three dimensions. The company's biotechnology tools enable 3D spatial analysis at scale, enabling clients to unlock unprecedented biological insights and accelerate drug discovery.
- Sector
- Healthcare
- HQ
- Stockholm, Sweden
- Founded
- 2024
- Employees
- 9
- Website
- cubasebio.com/
- Ownership
- Privately Held (backing)
CubaseBio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CubaseBio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CubaseBio in its N-PORT filings yet. We sweep new filings monthly.